Iradimed (IRMD) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $56.5 million.
- Iradimed's Cash & Equivalents rose 929.04% to $56.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.5 million, marking a year-over-year increase of 929.04%. This contributed to the annual value of $52.2 million for FY2024, which is 496.7% up from last year.
- Iradimed's Cash & Equivalents amounted to $56.5 million in Q3 2025, which was up 929.04% from $53.0 million recorded in Q2 2025.
- Iradimed's Cash & Equivalents' 5-year high stood at $62.0 million during Q4 2021, with a 5-year trough of $42.8 million in Q1 2023.
- For the 5-year period, Iradimed's Cash & Equivalents averaged around $51.8 million, with its median value being $51.7 million (2024).
- Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 2382.89% in 2021, then tumbled by 1591.42% in 2023.
- Over the past 5 years, Iradimed's Cash & Equivalents (Quarter) stood at $62.0 million in 2021, then dropped by 6.51% to $58.0 million in 2022, then fell by 14.15% to $49.8 million in 2023, then grew by 4.97% to $52.2 million in 2024, then increased by 8.22% to $56.5 million in 2025.
- Its Cash & Equivalents was $56.5 million in Q3 2025, compared to $53.0 million in Q2 2025 and $50.3 million in Q1 2025.